At 59, George LaVie (not his real name) faced an uncertain future. Based on rising PSA levels (prostate-specific antigen), he had undergone a transrectal ultrasound biopsy (TRUS) to attempt to determine the presence of disease. The results were negative.

As radiation treatments have advanced in complexity, treatment facilities such as the Eugene M. & Christine E. Lynn Cancer Institute at Boca Raton Regional Hospital have faced greater demands for accuracy and precision in treatment. “Having the additional degrees of freedom (DOF) made possible by CIVCO’s Protura robotic patient positioning system has been an important advance for our program,” said Tim R. Williams, M.D., medical director, Lynn Cancer Institute, Boca Raton Regional Hospital.

December 15, 2011 – Siemens Healthcare offers a new information source for anyone facing an X-ray, computed tomography (CT) or a nuclear medicine examination. At www.medicalradiation.com, medical journalists and Siemens experts provide patients and interested members of the general public with basic details regarding medical radiation – including the fundamentals of the physics involved, an introduction to imaging procedures and notes on minimizing radiation exposure. A glossary explains the most common technical terms in a succinct, readily comprehensible manner.

December 15, 2011 – A single center study recently published in the November 15, 2011 issue of the Journal of the American College of Cardiology (JACC) suggests that both cardiac computed tomography (cardiac CT) and cardiovascular magnetic resonance (CMR) are superior to transthoracic echocardiography (TTE) in the assessment of patients undergoing transcatheter aortic valve implantation (TAVI).

December 15, 2011 – Fujifilm Holdings Corp. announced today that it has entered into a definitive agreement with SonoSite Inc., a provider of bedside and point-of-care ultrasound technology, pursuant to which Fujifilm will acquire SonoSite for approximately $995 million (which includes amounts payable in connection with its convertible debt). The transaction was unanimously approved by the Boards of Directors of both companies.

By Greg Freiherr

As the dose wars in computed tomography (CT) draw to a close, a new one approaches, this one in mammography. The surprise should not be that this war is coming, but that it is taking so long to get here.

December 14, 2011 — Toshiba America Medical Systems Inc. unveiled the Adaptive Iterative Dose Reduction 3-D (AIDR 3-D), its next generation dose reduction technology, at RSNA 2011. Still pending 510(k) approval from the U.S. Food and Drug Administration (FDA), the software will be available on Toshiba’s Aquilion One, Aquilion Premium and Aquilion Prime (also pending 510(k) clearance) systems.

Adaptive Iterative Dose Reduction 3-D (AIDR 3-D)

HeliFX Aortic Securement System

Infrascanner Model 1000

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now